Budipine is a non-dopaminergic antiparkinsonian drug. The primary action of budipine is an indirect dopaminergic effect as shown by facilitation of dopamine (DA) release, inhibition of monoamineoxidasetype B (MAO-B) and of DA (re) up-take and stimulatio